Clinical Trial: Clinical Validation of Life’s Essential 8 (LE8) for Identifying High MAF-5 Liver Fibrosis Risk in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (China)

Posted On: 2026-09-25

China, Sept. 25 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Clinical Validation of Life’s Essential 8 (LE8) for Identifying High MAF-5 Liver Fibrosis Risk in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133335

Registration Time: 2026/09/24

Type: Observational study

Primary Sponsor: Shanghai Tongren Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=344182

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Clinical Validation of Life’s Essential 8 (LE8) for Identifying High MAF-5 Liver Fibrosis Risk in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (China)